var title_f40_17_41232="Alveolar proteinosis CT";
var content_f40_17_41232=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary alveolar proteinosis chest CT scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ground-glass opacification and thickened intralobular structures and interlobular septa, in typical polygonal shapes referred to as \"crazy-paving.\"",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Talmadge E King, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41232=[""].join("\n");
var outline_f40_17_41232=null;
var title_f40_17_41233="Localized granuloma annulare on hand";
var content_f40_17_41233=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma annulare, localized",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 27-year-old presented with a nine month history of a solitary, slowly enlarging, annular patch of granuloma annulare 10 cm in diameter on the right hand. It has 1 to 1.5 mm skin-colored papules at the periphery and complete clearing in the center of the lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41233=[""].join("\n");
var outline_f40_17_41233=null;
var title_f40_17_41234="Pinaverium: Drug information";
var content_f40_17_41234=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pinaverium: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/49/20244?source=see_link\">",
"    see \"Pinaverium: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F210072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dicetel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F210095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Calcium Channel Antagonist, Gastrointestinal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F210074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      IBS, biliary disorders:",
"     </b>",
"     Oral: Initial: 50 mg 3 times/day; dose may be increased up to 100 mg 3 times/day (maximum dose: 300 mg/day)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10076338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dicetel&reg;: 50 mg, 100 mg [contains lactose]",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11234247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F210061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not crush or chew tablet. Should be taken with a glass of water during meals or snacks. The tablet should",
"     <b>",
"      not",
"     </b>",
"     be swallowed when in the lying position or just before bedtime.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F210060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment and relief of symptoms associated with irritable bowel syndrome (IBS); treatment of symptoms related to functional disorders of the biliary tract",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F210094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal distension, anaphylactic shock, angioedema, constipation, diarrhea, drowsiness, dyspepsia, epigastric pain, headache, nausea, rash, vertigo, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F210063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pinaverium or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F210049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal irritation: May cause esophageal irritation; minimize risk by administering with a full glass of water with a meal/snack (do not crush/chew tablets). Patients must be advised not to take medication when lying down or at bedtime. Avoid use in patients with possible gastroesophageal reflux or hiatal hernia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; GI motility: Avoid using to treat motility dysfunction associated with underlying disease states.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hereditary galactose intolerance: Contains lactose; avoid use in patients with hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F210053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F210065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies are insufficient and information from human pregnancies is not available. The presence of bromine in the formulation poses a theoretical risk of causing neurologic effects (sedation, hypotony) to newborns if pinaverium is used late in pregnancy, though no such cases have been reported.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F210076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F210066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Manufacturer advises against administration in breast-feeding women.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F210067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken with a full glass of water during a meal/snack.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F210068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Dicetel (AR, AT, BE, BG, BR, CH, CL, CO, CZ, FR, GR, HN, HU, IT, KP, LU, NL, PE, PT, TH, TR, TW, UY, VE);",
"     </li>",
"     <li>",
"      Eldicet (CN, ES, IN, PH, PY);",
"     </li>",
"     <li>",
"      Pinar (PE);",
"     </li>",
"     <li>",
"      Tintel (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F210048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks influx of calcium via voltage-sensitive channels within smooth muscle cells of the gastrointestinal tract resulting in a spasmolytic effect in the gut.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F12935200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Poor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 97%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic via demethylation, hydroxylation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: &lt;1%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: ~1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Jailwala J, Imperiale TF, and Kroenke K, &ldquo;Pharmacologic Treatment of the Irritable Bowel Syndrome: A Systematic Review of Randomized, Controlled Trials,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2000, 133(2):136-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41234/abstract-text/10896640/pubmed\" id=\"10896640\" target=\"_blank\">",
"        10896640",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10080 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-AC55A795B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41234=[""].join("\n");
var outline_f40_17_41234=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210072\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210095\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210074\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062261\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10076338\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234247\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210061\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210060\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210094\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210063\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210049\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299881\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210053\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210065\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210076\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210066\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210067\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210068\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210048\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12935200\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10080\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10080|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/49/20244?source=related_link\">",
"      Pinaverium: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_17_41235="Vitamin A and vitamin D (topical): Patient drug information";
var content_f40_17_41235=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Vitamin A and vitamin D (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/21/13650?source=see_link\">",
"     see \"Vitamin A and vitamin D (topical): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F14332638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      A+D&reg; Original [OTC];",
"     </li>",
"     <li>",
"      Baza&reg; Clear [OTC];",
"     </li>",
"     <li>",
"      Sween Cream&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F14727059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2782459",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat diaper rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691826",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat dry skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692076",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F14727058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to vitamin A, vitamin D, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3688637",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a very bad burn or cut.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F14727063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F14727064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F14727065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F14727061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696250",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use. Do not wash your hands after use if putting this on your hand.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F14727062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F14727066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F14727067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 86235 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-76D4E16EBB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41235=[""].join("\n");
var outline_f40_17_41235=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14332638\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727059\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727058\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727063\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727064\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727065\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727061\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727062\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727066\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14727067\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/23/371?source=related_link\">",
"      Vitamin A and vitamin D (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/56/19331?source=related_link\">",
"      Vitamin A and vitamin D (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/21/13650?source=related_link\">",
"      Vitamin A and vitamin D (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_17_41236="Galantamine: Patient drug information";
var content_f40_17_41236=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Galantamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/27/6582?source=see_link\">",
"     see \"Galantamine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F175172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Razadyne&reg;;",
"     </li>",
"     <li>",
"      Razadyne&reg; ER",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F175173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Mylan-Galantamine ER;",
"     </li>",
"     <li>",
"      PAT-Galantamine ER;",
"     </li>",
"     <li>",
"      Reminyl&reg;;",
"     </li>",
"     <li>",
"      Reminyl&reg; ER",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691710",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Alzheimer's disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to galantamine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697142",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a slow heartbeat, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695796",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take tablet or solution at breakfast and dinner.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695771",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take long-acting products at breakfast.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696371",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills. Mix with",
"       <sup>",
"        1",
"       </sup>",
"       /",
"       <sub>",
"        2",
"       </sub>",
"       cup of liquid before drinking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it, with a meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696516",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you miss more than 3 days of this drug, start at the lowest dose and raise dose slowly to the dose you are using now. Stay at each dose for 4 weeks before going to next one.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect solution from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12505 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-218.7.204.202-35DACE4C3B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41236=[""].join("\n");
var outline_f40_17_41236=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F175172\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F175173\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016339\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016338\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016343\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016344\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016346\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016341\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016342\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016347\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016348\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/27/6582?source=related_link\">",
"      Galantamine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_17_41237="Normal lung anatomy PI";
var content_f40_17_41237=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F67527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F67527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Normal lungs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 542px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lungs sit in the chest, inside the ribcage. They are covered with a thin membrane called the \"pleura.\" The windpipe (or trachea) branches into two smaller airways called the left and right \"bronchus.\" The space between the lungs is called the \"mediastinum.\" Lymph nodes are located within and around the lungs and mediastinum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41237=[""].join("\n");
var outline_f40_17_41237=null;
var title_f40_17_41238="Conjugated equine estrogens (systemic): Patient drug information";
var content_f40_17_41238=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Conjugated equine estrogens (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/51/28472?source=see_link\">",
"     see \"Conjugated equine estrogens (systemic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/29/22998?source=see_link\">",
"     see \"Conjugated equine estrogens (systemic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8090832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Premarin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8090841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      C.E.S.&reg;;",
"     </li>",
"     <li>",
"      Congest;",
"     </li>",
"     <li>",
"      PMS-Conjugated Estrogens C.S.D.;",
"     </li>",
"     <li>",
"      Premarin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3576122",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Estrogens may raise your chances of having breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Estrogens, when used in women after stopping periods (menopause), may raise the chance of uterine cancer. Progestins may lower this chance. A warning sign for cancer of the uterus is vaginal bleeding. Report any vaginal bleeding to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take estrogens if you are pregnant. If you get pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3576124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take estrogens to stop heart disease or dementia. Using estrogens may raise your chances of having a heart attack, a stroke, or a blood clot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to add estrogen to the body when the ovaries have been taken out or do not work the right way.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691539",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off soft, brittle bones (osteoporosis) in women after change of life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691649",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or lower the signs of stopping periods (menopause).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692123",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat vaginal irritation and dryness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691688",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691754",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bleeding due to kidney failure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rarely, it is used to treat breast or prostate cancers.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to estrogens (conjugated/equine) or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3576222",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Blood clots, blood clotting problem, breast cancer (except in some cases where the cancer has spread), liver disease, recent heart attack, recent stroke, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697661",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be a higher chance of endometrial or breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high calcium levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697245",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had high triglyceride levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have porphyria, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a bone density test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027351\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697924",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Breast pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be days when you will not take this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695798",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take tablet with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705494",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Soft, brittle bones (osteoporosis):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11676 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-17F8E0A872-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41238=[""].join("\n");
var outline_f40_17_41238=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8090832\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8090841\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027344\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027346\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027345\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027350\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027351\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027353\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027348\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027349\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027354\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027355\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/51/28472?source=related_link\">",
"      Conjugated equine estrogens (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/29/22998?source=related_link\">",
"      Conjugated equine estrogens (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?18/60/19399?source=related_link\">",
"      Conjugated equine estrogens (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/48/17158?source=related_link\">",
"      Conjugated equine estrogens (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/30/14821?source=related_link\">",
"      Conjugated equine estrogens (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_17_41239="Hand symptom diagram CTS";
var content_f40_17_41239=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F61147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F61147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Hand symptom diagram for carpal tunnel syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 496px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A. Diagram-rated classic carpal tunnel syndrome (CTS) for both hands; nerve conduction tests confirmed bilateral CTS. B. Diagram-rated probable because of palmar symptoms; nerve conduction tests revealed right CTS. C. Diagram rated unlikely; nerve conduction tests indicated left ulnar nerve entrapment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn with permission from Katz JN, Stirrat CR, Larson MG, et al. A self-administered hand symptom diagram for the diagnosis and epidemiologic study of carpal tunnel syndrome.&nbsp;J Rheumatol 1990; 17:1495.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41239=[""].join("\n");
var outline_f40_17_41239=null;
var title_f40_17_41240="Etoposide: Pediatric drug information";
var content_f40_17_41240=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Etoposide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=see_link\">",
"    see \"Etoposide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/3/43061?source=see_link\">",
"    see \"Etoposide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Toposar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14225985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Etoposide Injection USP;",
"     </li>",
"     <li>",
"      Vepesid&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1047333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Mitotic Inhibitor",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Topoisomerase Inhibitor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1047325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=see_link\">",
"      see \"Etoposide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, and Adolescents: Refer to individual protocols; limited data available",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Acute lymphocytic leukemia (ALL), relapsed:",
"     </b>",
"     Children and Adolescents: I.V.: Consolidation: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 15-19 (in combination with other chemotherapeutic agents) (Parker, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Acute myeloid leukemia (AML):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Induction: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &lt;1 year: 75 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 1-5 (in combination with cytarabine and daunorubicin or mitoxantrone) (Gibson, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;1 year and Adolescents: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 1-5 (in combination with cytarabine and daunorubicin or mitoxantrone) (Gibson, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     BSA-directed dosing (Cooper, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     BSA &lt;0.6 m",
"     <sup>",
"      2",
"     </sup>",
"     : 3.3 mg/",
"     <b>",
"      kg",
"     </b>",
"     /dose once daily on days 1-5 (in combination with other chemotherapeutic agents)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     BSA &ge;0.6 m",
"     <sup>",
"      2",
"     </sup>",
"     : 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 1-5 (in combination with other chemotherapeutic agents)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intensification: I.V.: BSA-directed dosing (Cooper, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     BSA &lt;0.6 m",
"     <sup>",
"      2",
"     </sup>",
"     : 5 mg/",
"     <b>",
"      kg",
"     </b>",
"     /dose once daily on days 1-5 (in combination with cytarabine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     BSA &ge;0.6 m",
"     <sup>",
"      2",
"     </sup>",
"     : 150 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 1-5 (in combination with cytarabine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Consolidation: I.V.: Infants, Children, and Adolescents: IV: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily for 4-5 days, administered over 1 hour (in combination with cytarabine and daunorubicun or amsacrine) (Gibson, 2012; Perel, 2002); 75 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 1-5 (in combination with cytarabine and amsacrine) was administered to infants &lt;1 year in one study (Gibson, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      CNS tumor:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;3 years: 6.5 mg/",
"     <b>",
"      kg",
"     </b>",
"     /dose administered on days 3 and 4 (in combination with cisplatin as Cycle B regimen) for 28 day cycle alternating with Cycle A regimen (cyclophosphamide and vincristine); therapy initiated  2-4 weeks after tumor resection (Duffner, 1993)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;3 years and Adolescents: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily on days 1, 2, and 3 (in combination with vincristine and carboplatin or cyclophosphamide) every 3 weeks for 4 cycles prior to radiation (Taylor, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;6 years and Adolescents: 150 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily  on days 3 and 4 (in combination with cisplatin) every 3 weeks for 4 cycles prior to radiation (Kovnar, 1990)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hematopoietic stem cell transplantation (HSCT), conditioning regimen:",
"     </b>",
"     Children &ge;1 year and Adolescents: I.V.: 30",
"     <b>",
"      or",
"     </b>",
"     60 mg/kg/dose administered over 4-8 hours as a single dose 3 or 4 days prior to transplantation (Biagi, 2000; Duerst, 2000; Horning, 1994; Snyder, 1993; Zander, 1997)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hodgkin&rsquo;s lymphoma, advanced stage (BEACOPP regimen):",
"     </b>",
"     Induction: Children &ge;4 years and Adolescents: I.V.: 200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily  on days 0-2 (3 doses) every 3 weeks for 4 cycles (in combination with bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone); 4 additional cycles may be given to slow early responders (Kelly, 2002; Kelly, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Neuroblastoma, high-risk:",
"     </b>",
"     Children &ge;1 year and Adolescents: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Induction: I.V.: 100-200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 1-2 hours once daily for  3-5 consecutive days (in combination with other chemotherapy agents) (Kaneko, 2002; Kushner, 2004; Simon, 2007; Simon, 2007a); other reported regimens include 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose on day 2 and 5 (in combination with cisplatin, doxorubicin, and cyclophosphamide) every 28 days for 5 cycles (Matthay, 1999)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Myeloablative therapy with stem cell rescue:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.V.: 100-200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 4-5 days beginning 8-9 days prior to transplantation was used in 301 patients (Kaneko, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Continuous I.V. infusion: 640 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     infused over 96 hours beginning 8 days prior to transplant (Matthany, 1999; Park, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Sarcoma:",
"     </b>",
"     Children &ge;1 year and Adolescents: I.V.: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily  for 5 doses on days 0-4 every 3 weeks [in combination with ifosfamide and carboplatin (ICE regimen)]  (Van Winkle, 2005); other reported regimens include: 150 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily  for 3 doses on days 1-3 in combination with vincristine, doxorubicin, cyclophosphamide, and ifosfamide (VACIE regimen) (Navid, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Wilms tumor (ICE Regimen):",
"     </b>",
"     Children and Adolescents: I.V.: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily for 3-5 doses usually on days 1-5 of a 28-day cycle (in combination with ifosfamide and carboplatin) (Abu-Ghosh, 2002; Daw, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Small cell lung cancer (in combination with other chemotherapy agents):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: 35 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 4 days, up to 50 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 5 days every 3-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Due to poor bioavailability, oral doses should be twice the I.V. dose (and rounded to the nearest 50 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Testicular cancer (in combination with other chemotherapy agents):",
"     </b>",
"     I.V.: 50-100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day on days 1-5 or 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day on days 1, 3, and 5 every 3-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants, Children, and Adolescents: Dosage adjustments are not provided in the manufacturer&rsquo;s labeling; however, the following adjustments have been recommended (Aronoff, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR &gt;50 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : No dosage adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR 10-50 mL/minute/1.73m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer 75% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GFR &lt;10 mL/minute/1.73m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer 50% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hemodialysis/peritoneal dialysis (PD) (after dialysis on dialysis days): Administer 50% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): Administer 75% of dose and reduce for hyperbilirubinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Manufacturer&rsquo;s labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-50 mL/minute: Administer 75% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL minute: Data not available; consider further dose reductions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     The following guidelines have been used by some clinicians:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Aronoff, 2007:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute: Administer 75% of normal dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer 50% of normal dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Hemodialysis: Supplemental dose is not necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Peritoneal dialysis: Supplemental dose is not necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): Administer 75% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Kintzel, 1995:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     46-60 mL/minute: Administer 85% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     31-45 mL/minute: Administer 80% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;30 mL/minute: Administer 75% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment",
"     </b>",
"     (Floyd, 2006; Superfin, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bilirubin 1.5-3 mg/dL or AST &gt;3 times ULN: Administer 50% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bilirubin &gt;3 mg/dL: Administer 25% of dose or consider avoiding use",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F169256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, softgel, oral: 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 20 mg/mL (5 mL, 25 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Toposar&reg;: 20 mg/mL (5 mL, 25 mL, 50 mL) [contains dehydrated ethanol 33.2%, polyethylene glycol 300, polysorbate 80]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F169241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1047337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral:  In adults, doses &le;200 mg/day  should be given as a single daily dose; doses &gt;400 mg should be given in 2-4 divided doses. If necessary, the injection may be used for oral administration either as an extemporaneous preparation or by mixing dose with orange juice, apple juice, or lemonade at a final concentration not to exceed 0.4 mg/mL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Further dilute in NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W to a typical final concentration of 0.2-0.4 mg/mL to minimize hypotension risk; however, more concentrated I.V. solutions (0.6-1 mg/mL) may be used.  For high-dose etoposide infusions, undiluted etoposide (20 mg/mL) has been infused as a single dose from a glass syringe via syringe pump through a central venous catheter over 1-4 hours. Higher than recommended concentrations of etoposide infusions may  crack hard plastic in chemo venting pins and infusion lines; inspect infusion solution for particulate matter and plastic devices for cracks and leaks; pH:3-4",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     For I.V. infusion only; do not administer by rapid I.V. injection or by intrathecal, intraperitoneal, or intrapleural routes due to possible severe toxicity. Administer by continuous I.V. infusion or I.V. intermittent infusion via an in-line 0.22 micron filter over at least 60 minutes at a rate not to exceed 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /hour (or 3.3 mg/",
"     <b>",
"      kg",
"     </b>",
"     /hour).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F169339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR,  NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Allopurinol, amifostine, aztreonam, cladribine, doxorubicin liposomal, fludarabine, gemcitabine, granisetron, melphalan, methotrexate, micafungin, mitoxantrone, ondansetron, paclitaxel, piperacillin/tazobactam, sargramostim, sodium bicarbonate, teniposide, thiotepa, topotecan, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Cefepime, filgrastim, gallium nitrate, idarubicin.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1047328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsules: Store oral capsules at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: Store unopened vials at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); do not freeze. Undiluted etoposide injection may cause cracks and leaking when stored in acrylic or ABS (acrylonitrile, butadiene, and styrene) plastic containers.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stability of diluted injection is concentration dependent; more concentrated solutions have shorter stability (0.2 mg/mL: 96 hours; 0.4 mg/mL: 24 hours); incidence of precipitation increases with final concentrations &gt;0.4 mg/mL; at a concentration of 1 mg/mL in D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS, crystallization has occurred within 30 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1047336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of refractory testicular tumors (Parenteral: FDA approved in adults) and small cell lung cancer (Oral and parenteral: FDA approved in adults); has also been used for malignant lymphoma, Hodgkin's disease, leukemias (ALL, ANLL, AML), neuroblastoma; treatment of Ewing's sarcoma, rhabdomyosarcoma, osteosarcoma, Wilms' tumor, CNS tumors; conditioning regimen with hematopoietic stem cell transplantation",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F169342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Etoposide may be confused with teniposide",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Etoposide may be confused with etoposide phosphate (a prodrug of etoposide which is rapidly converted in the plasma to etoposide)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       VePesid may be confused with Versed",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F169338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     The following may occur with higher doses used in stem cell transplantation: Alopecia, ethanol intoxication, hepatitis, hypotension (infusion-related), metabolic acidosis, mucositis, nausea and vomiting (severe), secondary malignancy, skin lesions (resembling Stevens-Johnson syndrome).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypotension (due to rapid infusion)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal:  Abdominal pain, anorexia, diarrhea, nausea/vomiting, stomatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, leukopenia (nadir: 7-14 days; recovery: by day 20), thrombocytopenia (nadir 9-16 days; recovery: by day 20)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatic toxicity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Peripheral neuropathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylactic-like reaction (including chills, fever, tachycardia, bronchospasm, dyspnea)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Amenorrhea, blindness (transient/cortical), cyanosis, extravasation (induration/necrosis), facial swelling, hypersensitivity, hypersensitivity-associated apnea, interstitial pneumonitis, laryngospasm, maculopapular rash, metabolic acidosis, MI, mucositis, myocardial ischemia, optic neuritis, perivasculitis, pruritus, pulmonary fibrosis, radiation-recall dermatitis, rash, reversible posterior leukoencephalopathy syndrome (RPLS), seizure, Stevens-Johnson syndrome, tongue swelling, toxic epidermal necrolysis, toxic megacolon, vasospasm",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1047340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to etoposide or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1047324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and consider dosage reduction in patients with hepatic impairment, bone marrow suppression, and renal impairment. Use with caution in patients with low serum albumin; may increase risk for toxicities. Should be administered under the supervision of an experienced cancer chemotherapy physician",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1047323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Etoposide is mutagenic, potentially carcinogenic, teratogenic, and embryotoxic. Secondary acute leukemias have been reported with etoposide, either as monotherapy or in combination with other chemotherapy agents. Severe dose-limiting and dose-related myelosuppression with resulting infection or bleeding may occur",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; treatment should be withheld for platelets &lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     or absolute neutrophil count (ANC) &lt;500/mm",
"     <sup>",
"      3",
"     </sup>",
"     until counts recover. Hypotension may occur due to rapid infusion of etoposide; infuse slowly over at least 30-60 minutes. If hypotension occurs, interrupt infusion and administer I.V. hydration and supportive care; decrease infusion rate upon reinitiation.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Etoposide injection contains benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; use etoposide injection containing benzyl alcohol with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites. Etoposide injection also contains polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals. In premature neonates, thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported after receiving parenteral products containing polysorbate 80 (Alade, 1986; CDC, 1984). Infusion of polysorbate 80-containing solutions through PVC tubing may cause DEHP to leach into the solution; in immature animals, exposure to DEHP may adversely affect the development of the male reproductive tract.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Anaphylactic reactions including chills, fever, tachycardia, bronchospasm, dyspnea and hypotension have been reported with etoposide. In addition, facial/tongue swelling, coughing, chest tightness, cyanosis, laryngospasm, diaphoresis, hypertension, and flushing have also been reported less commonly. Incidence is primarily associated with intravenous administration (up to 2%) compared to oral administration (&lt;1%); concentration and rate of infusion may contribute to anaphylactic reactions. Higher rates of anaphylactoid reactions have been reported in children who received I.V. infusions of etoposide at higher than recommended concentrations. If a reaction occurs, discontinue infusion and provide appropriate supportive care. High drug concentration and rate of infusion, as well as presence of polysorbate 80 and benzyl alcohol in the etoposide intravenous formulation, have been suggested as contributing factors to the development of hypersensitivity reactions. Unlike etoposide injection, the water soluble prodrug formulation (etoposide phosphate) does not contain either  benzyl alcohol or polysorbate 80; case reports describe etoposide phosphate  success in patients with previous hypersensitivity reactions to etoposide (Collier, 2008; Siderov, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F169328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2E1 (minor), CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C9 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F169250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atovaquone: May increase the serum concentration of Etoposide. Management: Separate administration of atovaquone and etoposide by at least 1-2 days. Avoid concomitant administration of atovaquone and etoposide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): May decrease the metabolism of Etoposide. Management: Consider reducing the dose of etoposide by 50% if the patient is receiving, or has recently received, cyclosporine. Monitor for increased toxic effects of etoposide if cyclosporine is initiated, the dose is increased, or it has been recently discontinued.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Antineoplastic Agents may enhance the anticoagulant effect of Vitamin K Antagonists. Antineoplastic Agents may diminish the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Etoposide may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F169252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2565787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have demonstrated teratogenicity and fetal loss. There are no adequate and well-controlled studies in pregnant women. Women of childbearing potential should be advised to avoid pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1047332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential and platelet count, hemoglobin, vital signs (blood pressure), albumin, bilirubin, liver and renal function tests",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1047322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits mitotic activity; inhibits DNA type II topoisomerase producing single- and double-strand DNA breaks",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1047339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Large variability",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: CSF concentration is &lt;5% of plasma concentration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: V",
"     <sub>",
"      dss",
"     </sub>",
"     : 10 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: V",
"     <sub>",
"      dss",
"     </sub>",
"     : 7-17 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 94% to 97%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver (with a biphasic decay)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Averages 50% (range: 25% to 75%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, terminal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 4-15 hours with normal renal and hepatic function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Both unchanged drug and metabolites are excreted in urine and a small amount (2% to 16%) in feces; up to 55% of an I.V. dose is excreted unchanged in urine in children",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1047330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/3/43061?source=see_link\">",
"      see \"Etoposide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Notify physician if fever, sore throat, painful/burning urination, extreme fatigue, pain or numbness in extremities, yellowing of eyes or skin, bruising, bleeding or shortness of breath occurs",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F10938424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent: Use appropriate precautions for handling and disposal.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Etoposide 10 mg/mL oral solution: Dilute etoposide for injection 1:1 with normal saline to a concentration of 10 mg/mL. This solution is stable in plastic oral syringes for 22 days at room temperature.  Prior to oral administration, further mix with fruit juice (orange, apple, or lemon;",
"     <b>",
"      NOT",
"     </b>",
"     grapefruit juice) to a concentration of &lt;0.4 mg/mL; once mixed with fruit juice, use within 3 hours.",
"    </p>",
"    <div class=\"reference\">",
"     McLeod HL and Relling MV, &ldquo;Stability of Etoposide Solution for Oral Use,&rdquo;",
"     <i>",
"      Am J Hosp Pharm",
"     </i>",
"     , 1992, 49(11):2784-5.",
"     <span class=\"pubmed-id\">",
"      1471649",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Abu-Ghosh AM, Krailo MD, Goldman SC, et al, \"Ifosfamide, Carboplatin and Etoposide in Children With Poor-Risk Relapsed Wilms' Tumor: A Children's Cancer Group Report,\"",
"      <i>",
"       Ann Oncol",
"      </i>",
"      , 2002, 13(3):460-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/11996479/pubmed\" id=\"11996479\" target=\"_blank\">",
"        11996479",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Alade SL, Brown RE, and Paquet A Jr, \"Polysorbate 80 and E-Ferol Toxicity,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1986, 77(4):593-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/3960626/pubmed\" id=\"3960626\" target=\"_blank\">",
"        3960626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed, Philadelphia, PA: American College of Physicians; 2007.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berg SL, Grisell DL, DeLaney TF, et al, &ldquo;Principles of Treatment of Pediatric Solid Tumors,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1991, 38(2):249-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/2006077/pubmed\" id=\"2006077\" target=\"_blank\">",
"        2006077",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Biagi E, Rovelli A, Balduzzi A, et al, \"TBI, Etoposide and Cyclophosphamide as a Promising Conditioning Regimen for BMT in Childhood ALL in Second Remission,\"",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2000, 26(11):1260-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/11149746/pubmed\" id=\"11149746\" target=\"_blank\">",
"        11149746",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boos J, Kr&uuml;mpelmann S, Schulze-Westhoff P, et al, &ldquo;Steady-State Levels and Bone Marrow Toxicity of Etoposide in Children and Infants: Does Etoposide Require Age-Dependent Dose Calculation?&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1995, 13(12):2954-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/8523060/pubmed\" id=\"8523060\" target=\"_blank\">",
"        8523060",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control (CDC), \"Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 1984, 33(14):198-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/6423951/pubmed\" id=\"6423951\" target=\"_blank\">",
"        6423951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clark PI and Slevin ML, &ldquo;The Clinical Pharmacology of Etoposide and Teniposide,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1987, 12(4):223-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/3297462 /pubmed\" id=\"3297462 \" target=\"_blank\">",
"        3297462",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Collier K, Schink C, Young AM, et al, \"Successful Treatment With Etoposide Phosphate in Patients With Previous Etoposide Hypersensitivity,\"",
"      <i>",
"       J Oncol Pharm Pract",
"      </i>",
"      , 2008, 14(1):51-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/18337441/pubmed\" id=\"18337441\" target=\"_blank\">",
"        18337441",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cooper TM, Franklin J, Gerbing RB, et al, \"AAML03P1, A Pilot Study of the Safety of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Newly Diagnosed Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group,\"",
"      <i>",
"       Cancer",
"      </i>",
"      , 2012, 118(3):761-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/21766293/pubmed\" id=\"21766293\" target=\"_blank\">",
"        21766293",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Daw NC, Gregornik D, Rodman J, et al, \"Renal Function After Ifosfamide, Carboplatin and Etoposide (ICE) Chemotherapy, Nephrectomy and Radiotherapy in Children With Wilms Tumour,\"",
"      <i>",
"       Eur J Cancer",
"      </i>",
"      , 2009, 45(1):99-106.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/18996004/pubmed\" id=\"18996004\" target=\"_blank\">",
"        18996004",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Duerst RE, Horan JT, Liesveld JL, et al, \"Allogeneic Bone Marrow Transplantation for Children With Acute Leukemia: Cytoreduction With Fractionated Total Body Irradiation, High-Dose Etoposide and Cyclophosphamide,\"",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2000, 25(5):489-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/10713624/pubmed\" id=\"10713624\" target=\"_blank\">",
"        10713624",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Duffner PK, Horowitz ME, Krischer JP, et al, \"Postoperative Chemotherapy and Delayed Radiation in Children Less Than Three Years of Age With Malignant Brain Tumors,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 328(24):1725-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/8388548/pubmed\" id=\"8388548\" target=\"_blank\">",
"        8388548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Floyd J, Mirza I, Sachs B, et al, \"Hepatotoxicity of Chemotherapy,\"",
"      <i>",
"       Semin Oncol",
"      </i>",
"      , 2006, 33(1):50-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/16473644/pubmed\" id=\"16473644\" target=\"_blank\">",
"        16473644",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gibson BE, Webb DK, Howman AJ, et al, \"Results of a Randomized Trial in Children With Acute Myeloid Leukaemia: Medical Research Council AML12 Trial,\"",
"      <i>",
"       Br J Haematol",
"      </i>",
"      , 2011, 155(3):366-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/21902686/pubmed\" id=\"21902686\" target=\"_blank\">",
"        21902686",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Horning SJ, Negrin RS, Chao JC, et al, \"Fractionated Total-Body Irradiation, Etoposide, and Cyclophosphamide Plus Autografting in Hodgkin's Disease and Non-Hodgkin's Lymphoma,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1994, 12(12):2552-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/7989928/pubmed\" id=\"7989928\" target=\"_blank\">",
"        7989928",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kaneko M, Tsuchida Y, Mugishima H, et al, \"Intensified Chemotherapy Increases the Survival Rates in Patients With Stage 4 Neuroblastoma With MYCN Amplification,\"",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2002, 24(8):613-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/12439032/pubmed\" id=\"12439032\" target=\"_blank\">",
"        12439032",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kelly KM, Hutchinson RJ, Sposto R, et al, \"Feasibility of Upfront Dose-Intensive Chemotherapy in Children With Advanced-Stage Hodgkin's Lymphoma: Preliminary Results From the Children's Cancer Group Study CCG-59704,\"",
"      <i>",
"       Ann Oncol",
"      </i>",
"      , 2002,13 Suppl 1:107-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/12078889/pubmed\" id=\"12078889\" target=\"_blank\">",
"        12078889",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kelly KM, Sposto R, Hutchinson R, et al, \"BEACOPP Chemotherapy is a Highly Effective Regimen in Children and Adolescents With High-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2011, 117(9):2596-603.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/21079154/pubmed\" id=\"21079154\" target=\"_blank\">",
"        21079154",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kintzel PE and Dorr RT, \"Anticancer Drug Renal Toxicity and Elimination: Dosing Guidelines for Altered Renal Function,\"",
"      <i>",
"       Cancer Treat Rev",
"      </i>",
"      , 1995, 21(1):33-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/7859226/pubmed\" id=\"7859226\" target=\"_blank\">",
"        7859226",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kovnar EH, Kellie SJ, Horowitz ME, et al, \"Preirradiation Cisplatin and Etoposide in the Treatment of High-Risk Medulloblastoma and Other Malignant Embryonal Tumors of the Central Nervous System: A Phase II Study,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1990, 8(2):330-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/2153766/pubmed\" id=\"2153766\" target=\"_blank\">",
"        2153766",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kushner BH, Kramer K, LaQuaglia MP, et al, \"Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2004, 22(24):4888-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/15611504/pubmed\" id=\"15611504\" target=\"_blank\">",
"        15611504",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lazarus HM, Creger RJ, and Diaz D, &ldquo;Simple Method for the Administration of High-Dose Etoposide During Autologous Bone Marrow Transplantation,&rdquo;",
"      <i>",
"       Cancer Treat Rep",
"      </i>",
"      , 1986, 70(6):819-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/3524832/pubmed\" id=\"3524832\" target=\"_blank\">",
"        3524832",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Matthay KK, Villablanca JG, Seeger RC, et al, \"Treatment of High-Risk Neuroblastoma With Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-Cis-Retinoic Acid. Children's Cancer Group,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1999, 341(16):1165-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/10519894/pubmed\" id=\"10519894\" target=\"_blank\">",
"        10519894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Navid F, Santana VM, Billups CA, et al, \"Concomitant Administration of Vincristine, Doxorubicin, Cyclophosphamide, Ifosfamide, and Etoposide for High-Risk Sarcomas: The St. Jude Children's Research Hospital Experience,\"",
"      <i>",
"       Cancer",
"      </i>",
"      , 2006, 106(8):1846-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/16541446/pubmed\" id=\"16541446\" target=\"_blank\">",
"        16541446",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nishikawa A, Nakamura Y, Nobori U, et al, &ldquo;Acute Monocytic Leukemia in Children. Response to VP-16-213 as a Single Agent,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 1987, 60(9):2146-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/3326651 /pubmed\" id=\"3326651 \" target=\"_blank\">",
"        3326651",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      O'Dwyer PJ, Leyland-Jones B, Alonso MT, et al, &ldquo;Etoposide (VP-16-213): Current Status of an Active Anticancer Drug,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1985, 312(11):692-700.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/2983208 /pubmed\" id=\"2983208 \" target=\"_blank\">",
"        2983208",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Park JR, Villablanca JG, London WB, et al, \"Outcome of High-Risk Stage 3 Neuroblastoma With Myeloablative Therapy and 13-Cis-Retinoic Acid: A Report From the Children's Oncology Group,\"",
"      <i>",
"       Pediatr Blood Cancer",
"      </i>",
"      , 2009, 52(1):44-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/18937318/pubmed\" id=\"18937318\" target=\"_blank\">",
"        18937318",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Parker C, Waters R, Leighton C, \"Effect of Mitoxantrone on Outcome of Children With First Relapse of Acute Lymphoblastic Leukaemia (ALL R3): An Open-Label Randomised Trial,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2010, 376(9757):2009-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/21131038/pubmed\" id=\"21131038\" target=\"_blank\">",
"        21131038",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perel Y, Auvrignon A, Leblanc T, et al, \"Impact of Addition of Maintenance Therapy to Intensive Induction and Consolidation Chemotherapy for Childhood Acute Myeloblastic Leukemia: Results of a Prospective Randomized Trial, LAME 89/91. Leuc&aacute;mie Aiq&uuml;e My&eacute;lo&iuml;de Enfant,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2002, 20(12):2774-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/12065553/pubmed\" id=\"12065553\" target=\"_blank\">",
"        12065553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Siderov J, Prasad P, De Boer R, et al, \"Safe Administration of Etoposide Phosphate After Hypersensitivity Reaction to Intravenous Etoposide,\"",
"      <i>",
"       Br J Cancer",
"      </i>",
"      , 2002, 86(1):12-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/11857004/pubmed\" id=\"11857004\" target=\"_blank\">",
"        11857004",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simon T, L&auml;ngler A, Berthold F, et al, \"Topotecan and Etoposide in the Treatment of Relapsed High-Risk Neuroblastoma: Results of a Phase 2 Trial,\"",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2007, 29(2):101-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/17279006/pubmed\" id=\"17279006\" target=\"_blank\">",
"        17279006",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simon T, L&auml;ngler A, Harnischmacher U, et al, \"Topotecan, Cyclophosphamide, and Etoposide (TCE) in the Treatment of High-Risk Neuroblastoma. Results of a Phase-II Trial,\"",
"      <i>",
"       J Cancer Res Clin Oncol",
"      </i>",
"      , 2007a, 133(9):653-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/17479288/pubmed\" id=\"17479288\" target=\"_blank\">",
"        17479288",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Snyder DS, Chao NJ, Amylon MD, et al, \"Fractionated Total Body Irradiation and High-Dose Etoposide as a Preparatory Regimen for Bone Marrow Transplantation for 99 Patients With Acute Leukemia in First Complete Remission,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 1993, 82(9):2920-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/8219241/pubmed\" id=\"8219241\" target=\"_blank\">",
"        8219241",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Superfin D, Iannucci AA, and Davies AM, \"Commentary: Oncologic Drugs in Patients With Organ Dysfunction: A Summary,\"",
"      <i>",
"       Oncologist",
"      </i>",
"      , 2007, 12(9):1070-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/17914077/pubmed\" id=\"17914077\" target=\"_blank\">",
"        17914077",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taylor RE, Bailey CC, Robinson K, et al, \"Results of a Randomized Study of Preradiation Chemotherapy Versus Radiotherapy Alone for Nonmetastatic Medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2003, 21(8):1581-91.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Van Winkle P, Angiolillo A, Krailo M, et al, \"Ifosfamide, Carboplatin, and Etoposide (ICE) Reinduction Chemotherapy in a Large Cohort of Children and Adolescents With Recurrent/Refractory Sarcoma: The Children's Cancer Group (CCG) Experience,\"",
"      <i>",
"       Pediatr Blood Cancer",
"      </i>",
"      , 2005, 44(4):338-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/15503297/pubmed\" id=\"15503297\" target=\"_blank\">",
"        15503297",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zander AR, Berger C, Kr&ouml;ger N, et al, \"High Dose Chemotherapy With Busulfan, Cyclophosphamide, and Etoposide as Conditioning Regimen for Allogeneic Bone Marrow Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission,\"",
"      <i>",
"       Clin Cancer Res",
"      </i>",
"      , 1997, 3(12 Pt 2):2671-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/17/41240/abstract-text/10068272/pubmed\" id=\"10068272\" target=\"_blank\">",
"        10068272",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13292 Version 47.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-05EE575892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41240=[""].join("\n");
var outline_f40_17_41240=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708769\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169278\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14225985\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047333\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047325\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169256\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169241\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047337\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169339\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047328\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047336\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169342\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169338\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047340\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047324\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047323\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169328\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169250\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169252\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2565787\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047332\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047322\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047339\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047330\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10938424\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13292\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13292|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=related_link\">",
"      Etoposide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/3/43061?source=related_link\">",
"      Etoposide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_17_41241="Drug eruptions";
var content_f40_17_41241=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Drug eruptions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Andrew D Samel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Maja Mockenhaupt, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/17/41241/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/17/41241/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse cutaneous reactions to drugs are common, affecting 2 to 3 percent of hospitalized patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. It is estimated that 1 in 1000 hospitalized patients has a serious cutaneous drug reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. Adverse cutaneous reactions to drugs also are a significant cause of outpatient morbidity since many patients are labeled \"allergic\" to a medication. A variety of allergic reactions may be responsible for drug eruptions (",
"    <a class=\"graphic graphic_table graphicRef71375 \" href=\"mobipreview.htm?13/23/13692\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The dermatoses that are associated with drug administration will be reviewed here. Hypersensitivity reactions and cutaneous complications of antineoplastic drugs are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/57/43930?source=see_link\">",
"     \"Infusion reactions to systemic chemotherapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=see_link\">",
"     \"Cutaneous complications of conventional chemotherapy agents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIC DRUG REACTION PATTERNS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Drug-induced exanthems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug-induced exanthems are the most common cutaneous reactions to drugs, responsible for about 75 percent of all drug rashes. The most commonly prescribed medications (eg, antibiotics, sulfa) are implicated most often. The rashes are referred to as exanthems, morbilliform (",
"    <a class=\"graphic graphic_picture graphicRef54205 graphicRef70062 \" href=\"mobipreview.htm?36/36/37445\">",
"     picture 1A-B",
"    </a>",
"    ), and macular and papular eruptions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The eruptions begin in dependent areas and generalize, often with associated mucus membrane erythema. Pruritus is the most common symptom; low grade fever also can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ]. Blood eosinophilia may be present but is not a reliable finding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/3\">",
"     3",
"    </a>",
"    ]. Morbilliform eruptions can be the presenting signs of more serious reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), hypersensitivity syndrome, and serum sickness (see below and (",
"    <a class=\"graphic graphic_table graphicRef81148 \" href=\"mobipreview.htm?2/22/2414\">",
"     table 2",
"    </a>",
"    ))&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The onset of the eruption is usually within two weeks of beginning a new drug, and within days of reexposure if the patient was previously sensitized [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Occasionally, an eruption may begin as late as three weeks after beginning the drug, or first appear up to two weeks after the therapy was completed.",
"   </p>",
"   <p>",
"    Chemically related compounds (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ) can cause cross reactions, suggesting an allergic etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ]; the proposed mechanism of this reaction is delayed type IV hypersensitivity (cell mediated). This hypothesis is supported by histopathologic evidence and the increased rate of morbilliform eruption in patients with altered immunity (eg, HIV which has a 10-fold increased rate of reaction, and mononucleosis with its associated \"",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    rash\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Discontinuing the offending drug usually leads to resolution of the rash within 7 to 14 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/5\">",
"     5",
"    </a>",
"    ]; antihistamines, topical steroids and topical antipruritics are also helpful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. A drug may be continued in spite of a morbilliform eruption in rare instances when no alternative therapy is available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Urticaria/angioedema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urticaria, or hives, is characterized by an intensely pruritic, circumscribed, raised, and erythematous eruption with central pallor (",
"    <a class=\"graphic graphic_picture graphicRef72519 \" href=\"mobipreview.htm?29/2/29728\">",
"     picture 2",
"    </a>",
"    ). Individual lesions may enlarge, coalesce with other lesions, and typically disappear over a few hours. Urticaria is mediated by the cutaneous mast cell in the superficial dermis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/24/21898?source=see_link\">",
"     \"New onset urticaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Angioedema is swelling of the deeper dermis and subcutaneous tissues, which may coexist with urticaria in as many as 50 percent of cases. Angioedema may be disfiguring if it involves the face and lips, or life-threatening if airway obstruction occurs from laryngeal edema or tongue swelling. Angioedema can result from mast cell activation in the subcutaneous tissues, or by non-mast cell-mediated mechanisms. These mechanisms include abnormalities of the complement cascade (inherited and acquired abnormalities of complement metabolism), and increased activity of vasodilatory kinin pathways. Angioedema (in the absence of urticaria) occurs in 2 to 10 per 10,000 new users of ACE inhibitors and usually affects the mouth or tongue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/31/38391?source=see_link\">",
"     \"An overview of angioedema: Pathogenesis and causes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reactions involving",
"    <span class=\"nowrap\">",
"     urticaria/angioedema",
"    </span>",
"    can be immediate, accelerated (hours post-exposure) or delayed (days post-exposure). As with most drug eruptions, these reactions are more common during the first weeks of therapy, but can happen at any time.",
"   </p>",
"   <p>",
"    Urticaria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema may be manifestations of an IgE-mediated (type I hypersensitivity) drug reaction (",
"    <a class=\"graphic graphic_table graphicRef71375 \" href=\"mobipreview.htm?13/23/13692\">",
"     table 1",
"    </a>",
"    ). Antibiotics (especially penicillins, cephalosporins, and sulfonamides) are common causes of IgE-mediated drug allergy. IgE-mediated drug reactions tend to become more severe and progress toward anaphylaxis upon re-exposure to the causative agent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=see_link\">",
"     \"Allergy to penicillins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other drugs may cause urticaria due to mast cell degranulation by a non-IgE mediated mechanism. The most frequently implicated are the opiate analgesics",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    . The concomitant use of opiates and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    may increase the frequency of reactions to the latter. The intense flushing of \"Red man syndrome\" seen after rapid vancomycin infusion also is due to direct mast cell activation and may have accompanying urticaria. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/59/1978?source=see_link\">",
"     \"Vancomycin hypersensitivity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most severe form of immediate type I hypersensitivity is anaphylaxis, which is characterized by symptoms affecting multiple organ systems, including but not limited to pruritus, urticaria, angioedema, laryngeal edema, wheezing, nausea, vomiting, tachycardia, sense of impending doom, and occasionally shock. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hypersensitivity vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nomenclature of hypersensitivity vasculitis is diverse and often confusing. Names often used interchangeably but inappropriately have included drug-induced vasculitis, leukocytoclastic vasculitis, cutaneous vasculitis, serum sickness or serum sickness-like reactions, and allergic vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/6\">",
"     6",
"    </a>",
"    ]. The American College of Rheumatology proposed the following five criteria for the classification of hypersensitivity vasculitis in a patient with vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/7\">",
"     7",
"    </a>",
"    ]: (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30614?source=see_link\">",
"     \"Hypersensitivity vasculitis in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age &gt;16 years",
"     </li>",
"     <li>",
"      Use of a possible offending drug in temporal relation to the symptoms",
"     </li>",
"     <li>",
"      Palpable purpura (",
"      <a class=\"graphic graphic_picture graphicRef78697 \" href=\"mobipreview.htm?9/36/9794\">",
"       picture 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Maculopapular rash",
"     </li>",
"     <li>",
"      Biopsy of a skin lesion showing neutrophils around an arteriole or venule (",
"      <a class=\"graphic graphic_picture graphicRef52548 graphicRef66296 \" href=\"mobipreview.htm?7/58/8106\">",
"       picture 4A-B",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of three or more of these criteria had a sensitivity and specificity for the diagnosis of hypersensitivity vasculitis of 71 and 84 percent, respectively.",
"   </p>",
"   <p>",
"    Drugs are the most common cause of hypersensitivity vasculitis, although drug-induced vasculitis is a poorly defined disorder since proving causality is frequently difficult. There are virtually no reliable findings that prove vasculitis results directly from a particular exposure.",
"   </p>",
"   <p>",
"    Hypersensitivity vasculitis was, in the past, induced primarily by the administration of heterologous antisera (hence the name serum sickness). Currently, this disorder is typically caused by drugs that probably act as haptens to stimulate an immune response. The penicillins, cephalosporins, sulfonamides (including most loop and thiazide-type diuretics),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    have been most often implicated (",
"    <a class=\"graphic graphic_table graphicRef81148 \" href=\"mobipreview.htm?2/22/2414\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/6,8-10\">",
"     6,8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major clinical findings, in addition to the skin lesions, palpable purpura",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    petechiae, include fever, urticaria, arthralgias, lymphadenopathy, low serum complement levels, and an elevated erythrocyte sedimentation rate. In most patients, these symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    findings begin 7 to 10 days after antigen exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/6\">",
"     6",
"    </a>",
"    ]. However, the latent period may be as short as two to seven days with a secondary antigen exposure or longer than two weeks with a long-acting drug such as benzathine penicillin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Discontinuation of the inciting drug or antigen should lead to resolution of the signs and diagnosis within a period of days to a few weeks. Patients with more severe reactions may require nonsteroidal antiinflammatory drugs or corticosteroids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30614?source=see_link\">",
"     \"Hypersensitivity vasculitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Exfoliative dermatitis/erythroderma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythroderma is a cutaneous reactional state defined as chronic erythema and scale involving greater than 50 percent of the body surface area (",
"    <a class=\"graphic graphic_picture graphicRef62497 \" href=\"mobipreview.htm?22/43/23217\">",
"     picture 5",
"    </a>",
"    ). Common etiologies include drugs, primary skin disease (atopic dermatitis, psoriasis), and malignancy (especially lymphoreticular malignancy and cutaneous T-cell lymphoma). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/32/4618?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"    </a>",
"    .) Drugs are responsible for 10 percent of erythrodermas; implicated drugs include penicillins, barbiturates, gold salts, arsenic, and mercury (",
"    <a class=\"graphic graphic_picture graphicRef62321 \" href=\"mobipreview.htm?0/13/208\">",
"     picture 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This disorder is associated with an increased rate of epidermal turnover, including rapid epidermal cell migration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/11\">",
"     11",
"    </a>",
"    ]. This is presumably mediated by inflammatory cells and represents the most severe manifestation of many inflammatory dermatoses.",
"   </p>",
"   <p>",
"    Drug-induced erythroderma begins with a generalized eczema or morbilliform erythema accompanied by some irritation that increases steadily in severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. Eventually total body erythema with significant edema occurs. Fluid management and temperature homeostasis become paramount in the elderly and in those with severe chronic diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4963591\">",
"    <span class=\"h2\">",
"     Stevens-Johnson syndrome and toxic epidermal necrolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous eruptions that are frequently triggered by medications. These disorders are characterized by epidermal necrosis and sloughing of the mucous membranes and skin (",
"    <a class=\"graphic graphic_picture graphicRef76141 graphicRef73805 graphicRef59418 graphicRef68458 graphicRef82150 \" href=\"mobipreview.htm?41/47/42746\">",
"     picture 7A-E",
"    </a>",
"    ). The amount of body surface area involved is used to distinguish SJS from TEN; lesions affect less than 10 percent of the body surface in SJS and greater than 30 percent of the body surface in TEN. The clinical manifestations, diagnosis, and management of SJS and TEN are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33801?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Erythema multiforme",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythema multiforme (EM) majus (or erythema multiforme major) is sometimes used as a synonym for SJS but is considered to be a different condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1,12\">",
"     1,12",
"    </a>",
"    ]. It is an acute eruption characterized by distinctive target skin lesions. Lesions tend to affect the distal extremities, including the palms and soles (",
"    <a class=\"graphic graphic_picture graphicRef74095 \" href=\"mobipreview.htm?40/61/41951\">",
"     picture 8",
"    </a>",
"    ). EM has diagnostic histology and is often caused by infections (typically herpes simplex virus or Mycoplasma pneumoniae) and has a benign clinical course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. However, there are reports of EM in association with medication use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37672?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of erythema multiforme\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hypersensitivity syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypersensitivity syndrome, also described as drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS), is characterized by a severe idiosyncratic reaction including rash and fever, often with associated hepatitis, arthralgias, lymphadenopathy, or hematologic abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. The aromatic antiepileptic agents (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    ) and the sulfonamides are the most frequently implicated causes of this disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1,17,18,20,21\">",
"     1,17,18,20,21",
"    </a>",
"    ]. Abnormal detoxification of reactive arene oxide metabolites of the three aromatic anticonvulsants predisposes patients to these reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. The overall risk of hypersensitivity to phenytoin is in the range of 1:1000 to 1:10,000 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/56/41863?source=see_link\">",
"     \"Phenytoin poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hypersensitivity syndrome has also been reported to occur with nonaromatic anticonvulsants, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    and valproic acid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, multiple other drugs, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    , anti-infectives such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    , antidepressants, NSAIDS, angiotensin converting enzyme (ACE)-inhibitors, and beta blockers, have been implicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies suggest a role for human herpes virus 6 (HHV-6) in the pathogenesis of the drug-induced hypersensitivity syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/22,24\">",
"     22,24",
"    </a>",
"    ]. HHV-6 infection was detected by PCR in 6 of 7 patients with DRESS in one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/22\">",
"     22",
"    </a>",
"    ]; another study identified anti-HHV-6 IgM antibodies in four of seven patients with DRESS, and seropositivity for anti-HHV-6 in all seven patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/24\">",
"     24",
"    </a>",
"    ]. The role that HHV-6 plays in this disorder remains unclear.",
"   </p>",
"   <p>",
"    The hypersensitivity syndrome may be difficult to distinguish from serum sickness or vasculitis on clinical grounds. The reaction typically occurs two to six weeks after the drug is first used, which is later than most other serious skin reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ]. Classically, the patient presents with a morbilliform or erythrodermic eruption and may also have erythematous follicular papules, pustules, bullae, or purpura. The liver is the most commonly affected internal organ, but the syndrome can involve other sites, leading to findings such as pneumonitis, renal failure, myocarditis, thyroiditis, or neurologic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/22,23,25\">",
"     22,23,25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22986?source=see_link&amp;anchor=H8#H8\">",
"     \"Etiology and pathogenesis of myocarditis\", section on 'Hypersensitivity myocarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the cutaneous eruption, other findings on physical examination include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Facial edema",
"     </li>",
"     <li>",
"      Fever",
"     </li>",
"     <li>",
"      Lymphadenopathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The laboratory features help establish the diagnosis. Hepatitis is present in 51 percent, interstitial nephritis in 11 percent, and hematologic abnormalities (eosinophilia and circulating atypical monocytes) in 30 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The severity of the eruption and its associated laboratory abnormalities are in part related to the length of time the drug is continued after the onset of hypersensitivity. Recovery is usually complete, but the syndrome can be life-threatening in severe cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/22\">",
"     22",
"    </a>",
"    ]. Treatment includes discontinuing the suspected medication and frequently involves use of systemic glucocorticoids therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2,17\">",
"     2,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cross-sensitivity among",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    has been reported in 40 to 80 percent of patients with anticonvulsant hypersensitivity syndrome (AHS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/17\">",
"     17",
"    </a>",
"    ]. Thus, patients who develop AHS as a result of exposure to one of these medications should not be treated with any of the aromatic anticonvulsant drugs. In addition, patients with AHS should inform family members that they too may be at higher risk for severe adverse reactions to these medications, since susceptibility is believed to be partly genetic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypersensitivity reactions to sulfonamide medications are presented in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/2/23594?source=see_link\">",
"     \"Sulfonamide allergy in non HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Fixed drug eruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;A fixed drug eruption is a distinctive reaction characterized acutely by erythematous and edematous plaques with a grayish center or frank bullae, and chronically by a dark postinflammatory pigmentation (",
"    <a class=\"graphic graphic_picture graphicRef52192 graphicRef65991 \" href=\"mobipreview.htm?16/25/16792\">",
"     picture 9A-B",
"    </a>",
"    ). Favored sites include the mouth (lips and tongue), genitalia, face, and acral areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ]. The defining features of this eruption include the postinflammatory hyperpigmentation and the recurrence of lesions at exactly the same site with drug reexposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ]. The drugs commonly involved include phenolphthalein (laxatives), tetracyclines, barbiturates, sulfonamides, NSAIDs, and salicylates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2,26\">",
"     2,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/50/9000?source=see_link\">",
"     \"Fixed drug eruption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24703330\">",
"    <span class=\"h2\">",
"     Symmetrical drug-related intertriginous and flexural exanthema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE, intertriginous drug eruption, baboon syndrome) is an infrequent type of drug-induced rash. SDRIFE occurs a few hours to a few days after the administration of the offending drug. The rash presents as a sharply demarcated V-shaped erythema in the",
"    <span class=\"nowrap\">",
"     gluteal/perianal",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     inguinal/perigenital",
"    </span>",
"    areas, often with involvement of at least one other flexural or intertriginous fold, in the absence of systemic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/27\">",
"     27",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     Amoxicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    , penicillin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    are thought to be implied in about 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/27\">",
"     27",
"    </a>",
"    ]. Iodinate contrast media,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    , acetyl salicylic acid,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    C, phenothiazines,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/44/39622?source=see_link\">",
"     valacyclovir",
"    </a>",
"    , and many other drugs have also been implicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/28\">",
"     28",
"    </a>",
"    ]. Treatment includes discontinuing the suspected drug and the use of topical or systemic corticosteroids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Photosensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two basic types of photoeruptions: phototoxic and photoallergic, which differ in clinical appearance and pathogenesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=see_link&amp;anchor=H22#H22\">",
"     \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Phototoxicity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=see_link&amp;anchor=H25#H25\">",
"     \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Photoallergy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Phototoxic eruptions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phototoxic eruptions are by far the most common drug-induced photoeruption. They are caused by absorption of ultraviolet light by the causative drug, which releases energy and damages cells. Ultraviolet A light (UVA) is the most common wavelength implicated; ultraviolet B light (UVB) and visible light can elicit reactions with some drugs.",
"   </p>",
"   <p>",
"    The eruption is typically an exaggerated sunburn, often with blisters (",
"    <a class=\"graphic graphic_picture graphicRef86479 \" href=\"mobipreview.htm?35/46/36582\">",
"     picture 10",
"    </a>",
"    ). NSAIDs, quinolones, tetracyclines,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    , and the phenothiazines are the most frequent causes of phototoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Photoallergic eruptions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photoallergy is a lymphocyte-mediated reaction caused by exposure to UVA. It is postulated that the absorbed radiation converts the drug into an immunologically active compound that is then presented to lymphocytes by Langerhans cells, causing a spongiotic dermatitis (eczema). The eruption is characterized by widespread eczema in the photodistribution: face; upper chest; and back of hands (",
"    <a class=\"graphic graphic_picture graphicRef63557 \" href=\"mobipreview.htm?7/46/7907\">",
"     picture 11",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Most photoallergic reactions are caused by topical agents including biocides added to soaps (halogenated phenolic compounds) and fragrances such as musk ambrette and 6-methyl coumarin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/29\">",
"     29",
"    </a>",
"    ]. Systemic photoallergens such as the phenothiazines,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"     chlorpromazine",
"    </a>",
"    , sulfa products, and NSAIDs can produce photoallergic reactions, although most of their photosensitive reactions are phototoxic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     UNCOMMON DRUG ERUPTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pemphigus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pemphigus is an autoimmune blistering disease that may be drug-induced or drug-triggered. The latter term refers to unmasking of latent disease by a particular drug. The drugs most often implicated are",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    and other thiol (SH) compounds, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    or drugs such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/25/9625?source=see_link\">",
"     piroxicam",
"    </a>",
"    that are metabolized to thiols [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/30\">",
"     30",
"    </a>",
"    ]. Penicillin and its derivatives, but not cephalosporins, also have been implicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=see_link&amp;anchor=H118261971#H118261971\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of pemphigus\", section on 'Drug exposure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thiol-induced pemphigus can occur up to one year after beginning therapy. It presents as a superficial pemphigus with no mucosal involvement in 65 percent of cases, and is associated with antinuclear antibodies (ANA) in 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/31\">",
"     31",
"    </a>",
"    ]. Spontaneous remission is common (35 percent of cases).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bullous pemphigoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug-induced bullous pemphigoid develops in a small subgroup of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/6/4200?source=see_link\">",
"     Penicillamine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    are most frequently implicated, although cases associated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    , penicillin and its derivatives,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    , salicylazosulfapyridine, phenacetin, nalidixic acid, and topical",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    also have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/32\">",
"     32",
"    </a>",
"    ]. Most of the inducing drugs contain sulfhydryl groups that cleave epidermal intercellular substance, resulting in the production of the antibodies responsible for this disorder.",
"   </p>",
"   <p>",
"    Drug-induced bullous pemphigoid falls into two categories. It is either characterized by an acute, self-limited illness with resolution after drug withdrawal, or a chronic type that appears to be merely precipitated by drug administration and eventually assumes all the characteristics of the typical spontaneous variety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/32\">",
"     32",
"    </a>",
"    ]. Typical clinical manifestations include tense vesicles and bullae on an inflammatory base distributed on the arms, legs, and trunk of older patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Linear IgA bullous dermatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Linear IgA bullous dermatosis is an idiopathic subepidermal blistering disease characterized histologically by the linear deposition of IgA antibodies at the basement membrane zone. A spectrum of clinical features has been described. Patients with drug-induced disease may have erythema multiforme-type lesions, bullous pemphigoid-like lesions, or dermatitis herpetiformis-like lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/34\">",
"     34",
"    </a>",
"    ]. Mucosal or conjunctival lesions are not present in drug-induced disease but are common in the idiopathic form.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    is the most common drug implicated;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , cefamandole,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    have also been associated with this illness. Spontaneous remission occurs in drug-induced disease once the offending agent is discontinued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Acute generalized exanthematous pustulosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute generalized exanthematous pustulosis (AGEP) is a rare disorder characterized by the appearance of superficial pustules after drug ingestion or infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. AGEP is remarkable for its short time to onset (24 hours) after the administration of the suspected drug, although in some cases, the onset of symptoms may be delayed for up to three weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cutaneous eruption begins on the face or intertriginous areas and disseminates within a few hours. Nonfollicular small pustules arise on edematous erythema with burning",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    itching (",
"    <a class=\"graphic graphic_picture graphicRef56807 \" href=\"mobipreview.htm?39/59/40883\">",
"     picture 12",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef68610 \" href=\"mobipreview.htm?30/29/31189\">",
"     picture 13",
"    </a>",
"    ). Most patients have more than 100 pustules followed by desquamation. Edema of the face also may occur along with target skin lesions, purpura, and vesicles. Mild, non-erosive lesions occur in the mouth and tongue in about 20 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/35\">",
"     35",
"    </a>",
"    ]. Fever is common. The syndrome is generally self-limited, resolving spontaneously in approximately two weeks, although fatalities are reported in a small percentage of cases (ie, 5 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/38\">",
"     38",
"    </a>",
"    ]. AGEP can recur upon reexposure to the culprit drug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory features of AGEP can include a leukocytosis with elevated neutrophil counts and mild eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/35\">",
"     35",
"    </a>",
"    ]. Histologic examination reveals subcorneal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intraepidermal spongiform pustules, papillary dermal edema, and a perivascular lymphohistiocytic infiltrate with eosinophils and neutrophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/39\">",
"     39",
"    </a>",
"    ]. Dermal vasculitis and single-cell keratinocyte necrosis are seen in some cases. Histopathology can be helpful for distinguishing AGEP from acute pustular psoriasis, for which the clinical presentation may closely resemble AGEP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30393?source=see_link\">",
"     \"Neutrophilic dermatoses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibiotics are thought to play a role in 80 percent of cases. Penicillins and macrolide antibiotics were implicated in 62 percent of cases where there was a strong suspicion of drug-related AGEP in one report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/36\">",
"     36",
"    </a>",
"    ]. In a multinational case-control study, pristinamycin, aminopenicillins, quinolones,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    , sulfonamides,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/22/33120?source=see_link\">",
"     terbinafine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    were found to be highly associated with AGEP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/40\">",
"     40",
"    </a>",
"    ]. Additional drugs with less strong associations with the disorder included glucocorticoids, macrolides, NSAIDs, and antiepileptics. Patch testing has been utilized for identification of the inciting drug, but may be negative in up to 50 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/37\">",
"     37",
"    </a>",
"    ]. The occurrence of a generalized pustular reaction secondary to patch testing has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infection is a less common precipitator of AGEP. Cases have been associated with viral infections such as enteroviruses, parvovirus B19, adenovirus, Epstein-Barr virus, cytomegalovirus, and hepatitis B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/42\">",
"     42",
"    </a>",
"    ]. Isolated cases induced by Mycoplasma pneumoniae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/43\">",
"     43",
"    </a>",
"    ], Chlamydia pneumoniae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/44\">",
"     44",
"    </a>",
"    ], or Escherichia coli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/45\">",
"     45",
"    </a>",
"    ] infection have also been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Drug-induced lichen planus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen planus is characterized by flat-topped, violaceous, pruritic papules (",
"    <a class=\"graphic graphic_picture graphicRef80165 graphicRef59258 graphicRef59807 \" href=\"mobipreview.htm?33/17/34074\">",
"     picture 14A-C",
"    </a>",
"    ). The drug-induced form of this disorder usually develops insidiously and can affect any area of the body surface. Oral lesions occur in 30 to 70 percent of cases; the mucosa may be painful and ulcerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Beta-blockers,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/15/28918?source=see_link\">",
"     methyldopa",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    , and NSAIDs may cause this disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/46\">",
"     46",
"    </a>",
"    ]. Case reports have also been described with ACE inhibitors, sulfonylurea agents, tumor necrosis factor (TNF) alpha inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/47\">",
"     47",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , gold, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Alopecia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs cause hair loss by two major mechanisms: inducing an abrupt cessation of mitotic activity in rapidly dividing hair matrix cells (anagen effluvium); or precipitating the follicles into premature rest (telogen effluvium). In the former, hair loss usually occurs within days to weeks of drug administration; in the latter, hair loss occurs two to four months after starting treatment.",
"   </p>",
"   <p>",
"    Anagen effluvium is seen most commonly with antineoplastic drugs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/12/44232?source=see_link\">",
"     \"Chemotherapy-induced alopecia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Telogen effluvium is seen in association with many drugs including anticoagulants, retinoids, interferons, and antihyperlipidemic drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cutaneous pseudolymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antidepressant therapy (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    hydrochloride and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    hydrochloride) and other agents have been linked with benign hyperplastic lymphoid infiltrates of the skin (cutaneous pseudolymphoma) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/19,49\">",
"     19,49",
"    </a>",
"    ]. These drugs apparently suppress certain lymphoid functions and promote tumor growth. The lesions are often solitary or few in number and most often are nodular. Various histologic variations are noted, including a mycosis fungoides-like pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other drugs that have been implicated include calcium channel blockers, ACE inhibitors, antidepressants, antihistamines, beta blockers, benzodiazepines, and lipid lowering agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In most patients the skin lesions resolve when the offending drug is discontinued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Acral chemotherapy reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acral erythema (also called hand-foot syndrome or palmar-plantar erythrodysesthesia) occurs most commonly in patients with cancer who have been treated with cytosine arabinoside,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    (an oral 5-",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    derivative), or the small molecule tyrosine kinase inhibitors",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/45/9944?source=see_link\">",
"     sorafenib",
"    </a>",
"    . Intense macular erythema of the palmar and plantar surfaces is preceded by dysesthesia in the involved areas. Blisters may occur. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=see_link&amp;anchor=H23#H23\">",
"     \"Cutaneous complications of conventional chemotherapy agents\", section on 'Acral erythema (hand-foot skin reaction)'",
"    </a>",
"    .) and (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/63/35834?source=see_link&amp;anchor=H10#H10\">",
"     \"Cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy\", section on 'Hand-foot skin reaction'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A toxic drug reaction caused by the associated chemotherapy agent is the suspected cause of this disorder. Other contributing factors include the high concentration of eccrine glands of the palms and soles (drugs are often secreted through eccrine glands), relatively rapidly dividing",
"    <span class=\"nowrap\">",
"     palm/sole",
"    </span>",
"    skin, temperature gradients present in acral areas, and the vascular anatomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/53\">",
"     53",
"    </a>",
"    ]. Pyridoxine at oral doses of 50 to 150 mg per day has been useful in managing acral erythema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Drug-induced lupus",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two ways in which certain drugs may interact with lupus: they might exacerbate underlying lupus or induce lupus in a predisposed patient; or they might cause the separate syndrome of drug-induced lupus. Although early studies suggested that penicillin, sulfonamides, and anticonvulsant drugs might exacerbate underlying lupus, current opinion suggests that these patients had lupus and were receiving appropriate medications.",
"   </p>",
"   <p>",
"    More common and well-defined is the syndrome of drug-induced lupus, which is similar to spontaneous lupus but also has some different clinical and immunologic features (",
"    <a class=\"graphic graphic_table graphicRef69467 \" href=\"mobipreview.htm?14/62/15341\">",
"     table 3",
"    </a>",
"    ). A variety of drugs can induce a lupus-like syndrome, particularly those agents that are metabolized by acetylation such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"     hydralazine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/32/28168?source=see_link\">",
"     \"Drug-induced lupus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DRUGS OF SPECIAL CONCERN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H460534\">",
"    <span class=\"h2\">",
"     Anticoagulants",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H460547\">",
"    <span class=\"h3\">",
"     Warfarin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    -induced skin necrosis typically occurs during the first several days of warfarin therapy, often in association with the administration of large loading doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/56\">",
"     56",
"    </a>",
"    ]. The skin lesions occur on the extremities, breasts, trunk, and penis (in males) and marginate over a period of hours from an initial central erythematous macule (",
"    <a class=\"graphic graphic_picture graphicRef80462 \" href=\"mobipreview.htm?42/34/43553\">",
"     picture 15",
"    </a>",
"    ). Biopsies demonstrate fibrin thrombi within cutaneous vessels with interstitial hemorrhage.",
"   </p>",
"   <p>",
"    Skin necrosis appears to be mediated by the reduction in protein C levels on the first day of therapy, which induces a transient hypercoagulable state. Approximately one-third of patients have underlying protein C deficiency, although skin necrosis is an infrequent complication of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy among patients with protein C deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/57\">",
"     57",
"    </a>",
"    ]. Case reports have also described this syndrome in association with an acquired functional deficiency of protein C, heterozygous protein S deficiency, and factor V Leiden. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/52/841?source=see_link&amp;anchor=H13#H13\">",
"     \"Protein C deficiency\", section on 'Warfarin-induced skin necrosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H460596\">",
"    <span class=\"h3\">",
"     Heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     Heparin",
"    </a>",
"    may induce several skin reactions including delayed-type hypersensitivity reactions and, rarely, immediate hypersensitivity reactions or skin necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/58\">",
"     58",
"    </a>",
"    ]. Delayed-type hypersensitivity reactions may occur with both unfractionated and low-molecular-weight heparins, generally within two weeks of heparin treatment. Delayed-type reactions present most often with localized erythema at the injection site, but may progress to generalized eczematous or maculopapular eruption.",
"   </p>",
"   <p>",
"    Immediate hypersensitivity reactions are rare and manifest as anaphylactic (IgE mediated) or anaphylactoid (non-IgE mediated) reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/59\">",
"     59",
"    </a>",
"    ]. Clinical symptoms include localized or generalized urticaria, hypotension, angioedema, allergic rhinoconjunctivitis, tachycardia, or bronchospasm.",
"   </p>",
"   <p>",
"    Skin necrosis may develop in 10 to 20 percent of patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    -induced immune-mediated thrombocytopenia, a rare and life-threatening complication of treatment with unfractionated or low molecular-weight heparins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Cutaneous necrosis is caused by intradermal microvascular thromboses occurring locally or distantly from the injection site. Lesions appear 3 to 15 days after the initiation of therapy as erythematous patches that progress to skin necrosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=see_link&amp;anchor=H13#H13\">",
"     \"Heparin-induced thrombocytopenia\", section on 'Skin necrosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Gold",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatitis and stomatitis account for most adverse gold reactions. Gold rashes are highly variable and may mimic many other skin conditions. In a prospective study of 74 patients with rheumatoid arthritis, 39 patients developed a mucocutaneous reaction to gold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/62\">",
"     62",
"    </a>",
"    ]. A variety of morphologic features were noted, the bulk of which were characterized as nonspecific dermatitis (6 of these patients had an associated stomatitis, 6 had a dyshidrotic eczema presentation). In 3 patients the reaction resembled contact dermatitis. One case each of pityriasis rosea, lichen planus, psoriasis, erythema multiforme, pigmentary purpura, and vasculitis was reported. Most patients had pruritus. Gold-associated eruptions had a median duration of two months, with a range of one week to two years. Most cases resolved promptly with discontinuation of gold or with dose reduction; application of topical steroids was also helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Lithium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous side effects from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    therapy have been reported in 3 to 34 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psoriasis is one of the most common reactions. It may begin for the first time during therapy, or a mild case may be exacerbated when the patient begins the drug.",
"     </li>",
"     <li>",
"      Acne and acneiform eruptions also are common. Pustular lesions may be the result of lysosomal enzyme release and increased neutrophil chemotaxis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/63\">",
"       63",
"      </a>",
"      ]. Acneiform lesions may be seen on the forearms and legs in addition to the sites commonly involved in acne vulgaris.",
"     </li>",
"     <li>",
"      Hair loss, especially in women during the first few months of therapy, has frequently been reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Halogenoderma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ingestion of halogens such as iodides, bromides, and fluorides can rarely cause cutaneous drug reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Iodides (such as those in seaweed, salt,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    , and radiocontrast media) can cause acneiform lesions, typically on the face, as well as vesicular, pustular, hemorrhagic, urticarial, fungating, suppurative, nodular, and ulcerative lesions. Swelling of the parotid and submandibular glands has been previously described as iodine mumps. Iododerma due to the administration of intravenous radiocontrast media commonly is seen as an acute eruption; with oral iodine exposure the onset is insidious [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/65\">",
"     65",
"    </a>",
"    ]. Declining renal function may be a factor in radiocontrast induced iododerma.",
"   </p>",
"   <p>",
"    Bromides can cause verrucous ulcerating plaques on the lower extremities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Discontinuation of the causative agent is sufficient in most patients, with gradual resolution of lesions expected over four to six weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Cytokine therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematopoietic colony stimulating factors are a heterogeneous group of cytokines that induce proliferation and differentiation of bone marrow precursor cells. They are most frequently administered in the setting of neutropenia secondary to chemotherapy (eg, recombinant human granulocyte or granulocyte-macrophage colony-stimulating factor). Serious cutaneous adverse effects of colony stimulating factors are distinctly rare but include neutrophilic dermatoses and necrotizing vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/17/41241/abstract/66\">",
"     66",
"    </a>",
"    ]. Upregulation of neutrophil function and secondary release of cytokines may induce these complications.",
"   </p>",
"   <p>",
"    Both bullous pyoderma gangrenosum and Sweet syndrome have been associated with hematologic malignancies (particularly acute myeloid leukemia [AML]). It has not been proven that AML cells secrete",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/13/23767?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    .",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/1\">",
"      Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331:1272.",
"     </a>",
"    </li>",
"    <li>",
"     Stern RS, Shear NH. Cutaneous reactions to drugs and biological modifiers. In: Cutaneous Medicine and Surgery, Arndt KA, LeBoit PE, Robinson JK, Wintroub BU (Eds), WB Saunders, Philadelphia 1996. Vol 1, p.412.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/3\">",
"      Yawalkar N. Drug-induced exanthems. Toxicology 2005; 209:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/4\">",
"      Segal AR, Doherty KM, Leggott J, Zlotoff B. Cutaneous reactions to drugs in children. Pediatrics 2007; 120:e1082.",
"     </a>",
"    </li>",
"    <li>",
"     Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Fitzpatrick's dermatology in general medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw Hill, 2008. p.355.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/6\">",
"      Calabrese LH, Duna GF. Drug-induced vasculitis. Curr Opin Rheumatol 1996; 8:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/7\">",
"      Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990; 33:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/8\">",
"      Parker CW. Allergic reactions in man. Pharmacol Rev 1982; 34:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/9\">",
"      Mullick FG, McAllister HA Jr, Wagner BM, Fenoglio JJ Jr. Drug related vasculitis. Clinicopathologic correlations in 30 patients. Hum Pathol 1979; 10:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/10\">",
"      Martinez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodriguez-Valverde V. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med 1997; 102:186.",
"     </a>",
"    </li>",
"    <li>",
"     Dermatology in General Medicine, 4th ed, Fitzpatrick TB, Eisen AZ, Wolff K, et al (Eds), McGraw-Hill, New York 1993. p.528.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/12\">",
"      Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/13\">",
"      de Frutos C, de Barrio M, Tornero P, et al. Erythema multiforme from sulfaguanidine. Contact Dermatitis 2002; 46:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/14\">",
"      Forman R, Koren G, Shear NH. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf 2002; 25:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/15\">",
"      Ziemer M, Wiesend CL, Vetter R, et al. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 2007; 143:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/16\">",
"      Conger LA Jr, Grabski WJ. Dilantin hypersensitivity reaction. Cutis 1996; 57:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/17\">",
"      Bohan KH, Mansuri TF, Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 2007; 27:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/18\">",
"      Gogtay NJ, Bavdekar SB, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: a review. Expert Opin Drug Saf 2005; 4:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/19\">",
"      Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/20\">",
"      Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007; 48:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/21\">",
"      Yang CY, Dao RL, Lee TJ, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 2011; 77:2025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/22\">",
"      Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009; 145:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/23\">",
"      Ganeva M, Gancheva T, Lazarova R, et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 2008; 47:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/24\">",
"      Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/25\">",
"      Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/26\">",
"      Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002; 89:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/27\">",
"      H&auml;usermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004; 51:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/28\">",
"      Thyssen JP, Maibach HI. Drug-elicited systemic allergic (contact) dermatitis--update and possible pathomechanisms. Contact Dermatitis 2008; 59:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/29\">",
"      Gonz&aacute;lez E, Gonz&aacute;lez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996; 35:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/30\">",
"      Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998; 16:393.",
"     </a>",
"    </li>",
"    <li>",
"     Stern RS, Shear NH. Cutaneous reactions to drugs and biological modifiers. In: Cutaneous Medicine and Surgery, Arndt KA, LeBoit PE, Robinson JK, Wintroub BU (Eds), W.B. Saunders, Philadelphia 1996. Vol 1, p.412.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/32\">",
"      Smith EP, Taylor TB, Meyer LJ, Zone JJ. Antigen identification in drug-induced bullous pemphigoid. J Am Acad Dermatol 1993; 29:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/33\">",
"      Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 1998; 16:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/34\">",
"      Kuechle MK, Stegemeir E, Maynard B, et al. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 1994; 30:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/35\">",
"      Halevy S. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol 2009; 9:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/36\">",
"      Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/37\">",
"      Momin SB, Del Rosso JQ, Michaels B, Mobini N. Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction. Cutis 2009; 83:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/38\">",
"      Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209:123.",
"     </a>",
"    </li>",
"    <li>",
"     Horn TD, Hiatt KM. Cutaneous toxicities of drugs. In: Lever's Histopathology of the Skin, 9th ed, Elder DE, Elenitsas R, Johnson BL, et al (Eds), Lippincott Williams and Wilkins, Philadelphia 2005. p.323.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/40\">",
"      Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007; 157:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/41\">",
"      Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 2003; 139:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/42\">",
"      Guevara-Gutierrez E, Uribe-Jimenez E, Diaz-Canchola M, Tlacuilo-Parra A. Acute generalized exanthematous pustulosis: report of 12 cases and literature review. Int J Dermatol 2009; 48:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/43\">",
"      Lim CS, Lim SL. Acute generalized exanthematous pustulosis associated with asymptomatic Mycoplasma pneumoniae infection. Arch Dermatol 2009; 145:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/44\">",
"      Manzano S, Guggisberg D, Hammann C, Laubscher B. [Acute generalized exanthematous pustulosis: first case associated with a Chlamydia pneumoniae infection]. Arch Pediatr 2006; 13:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/45\">",
"      Klein N, Hartmann M, Helmbold P, Enk A. [Acute generalized exanthematous pustulosis associated with recurrent urinary tract infections]. Hautarzt 2009; 60:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/46\">",
"      Thompson DF, Skaehill PA. Drug-induced lichen planus. Pharmacotherapy 1994; 14:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/47\">",
"      Asarch A, Gottlieb AB, Lee J, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 2009; 61:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/48\">",
"      Tosi A, Misciali C, Piraccini BM, et al. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 1994; 10:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/49\">",
"      Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin Cutan Med Surg 2000; 19:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/50\">",
"      Crowson AN, Magro CM. Antidepressant therapy. A possible cause of atypical cutaneous lymphoid hyperplasia. Arch Dermatol 1995; 131:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/51\">",
"      Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Hum Pathol 1996; 27:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/52\">",
"      Cogrel O, Beylot-Barry M, Vergier B, et al. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Br J Dermatol 2001; 144:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/53\">",
"      Cohen PR. Acral erythema: a clinical review. Cutis 1993; 51:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/54\">",
"      Hess E. Drug-related lupus. N Engl J Med 1988; 318:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/55\">",
"      Fritzler MJ. Drugs recently associated with lupus syndromes. Lupus 1994; 3:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/56\">",
"      Bauer KA. Coumarin-induced skin necrosis. Arch Dermatol 1993; 129:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/57\">",
"      Broekmans AW, Teepe RG, van der Meer FJ, et al. Protein C (PC) and coumarin-induced skin necrosis. Thromb Res 1986; 6:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/58\">",
"      Schindewolf M, Lindhoff-Last E, Ludwig RJ, Boehncke WH. Heparin-induced skin lesions. Lancet 2012; 380:1867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/59\">",
"      Warkentin TE, Greinacher A. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opin Drug Saf 2009; 8:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/60\">",
"      Menajovsky LB. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med 2005; 118 Suppl 8A:21S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/61\">",
"      Handschin AE, Trentz O, Kock HJ, Wanner GA. Low molecular weight heparin-induced skin necrosis-a systematic review. Langenbecks Arch Surg 2005; 390:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/62\">",
"      Sack U, Kuhn H, Ermann J, et al. Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol 1994; 21:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/63\">",
"      Gupta AK, Knowles SR, Gupta MA, et al. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995; 32:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/64\">",
"      Crowson AN, Brown TJ, Magro CM. Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions : implications for management. Am J Clin Dermatol 2003; 4:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/65\">",
"      Chang MW, Miner JE, Moiin A, Hashimoto K. Iododerma after computed tomographic scan with intravenous radiopaque contrast media. J Am Acad Dermatol 1997; 36:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/17/41241/abstract/66\">",
"      Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994; 130:77.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2089 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-41275854C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41241=[""].join("\n");
var outline_f40_17_41241=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIC DRUG REACTION PATTERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Drug-induced exanthems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Urticaria/angioedema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hypersensitivity vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Exfoliative dermatitis/erythroderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4963591\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hypersensitivity syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Fixed drug eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24703330\">",
"      Symmetrical drug-related intertriginous and flexural exanthema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Photosensitivity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Phototoxic eruptions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Photoallergic eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      UNCOMMON DRUG ERUPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pemphigus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bullous pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Linear IgA bullous dermatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Acute generalized exanthematous pustulosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Drug-induced lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Alopecia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cutaneous pseudolymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Acral chemotherapy reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Drug-induced lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DRUGS OF SPECIAL CONCERN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H460534\">",
"      Anticoagulants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H460547\">",
"      - Warfarin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H460596\">",
"      - Heparin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Gold",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Lithium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Halogenoderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Cytokine therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/2089\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/2089|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/6/37985\" title=\"picture 1A\">",
"      Morbilliform drug eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/30/32239\" title=\"picture 1B\">",
"      Morbilliform eruption 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/2/29728\" title=\"picture 2\">",
"      Urticaria 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/36/9794\" title=\"picture 3\">",
"      Leukocytoclastic vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/20/43333\" title=\"picture 4A\">",
"      Leukocytoclastic vasculitis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/37/23126\" title=\"picture 4B\">",
"      Leukocytoclastic vasculitis II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/43/23217\" title=\"picture 5\">",
"      Erythroderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/13/208\" title=\"picture 6\">",
"      Drug induced exfoliation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/25/27030\" title=\"picture 7A\">",
"      Cutaneous findings of Stevens Johnson syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/7/30836\" title=\"picture 7B\">",
"      Mucosal changes in Stevens-Johnson syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/27/13747\" title=\"picture 7C\">",
"      Toxic epidermal necrolysis - abdomen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/1/39953\" title=\"picture 7D\">",
"      Toxic epidermal necrolysis - back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/18/35106\" title=\"picture 7E\">",
"      Toxic epidermal necrolysis - bullae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?40/61/41951\" title=\"picture 8\">",
"      Erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/19/16691\" title=\"picture 9A\">",
"      Fixed drug eruption arm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/16/10499\" title=\"picture 9B\">",
"      Fixed drug eruption penis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/46/36582\" title=\"picture 10\">",
"      Phototoxic eruption new",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/46/7907\" title=\"picture 11\">",
"      Photoallergic eruption 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/59/40883\" title=\"picture 12\">",
"      AGEP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/29/31189\" title=\"picture 13\">",
"      AGEP detail",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/5/40021\" title=\"picture 14A\">",
"      Lichenoid drug eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/33/35348\" title=\"picture 14B\">",
"      Lichenoid drug eruption hyperpigmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/46/39652\" title=\"picture 14C\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/34/43553\" title=\"picture 15\">",
"      Cutaneous necrosis warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/2089|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/23/13692\" title=\"table 1\">",
"      Types of allergic reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/22/2414\" title=\"table 2\">",
"      Drugs cutaneous vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/62/15341\" title=\"table 3\">",
"      Features of drug induced LE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=related_link\">",
"      Allergy to penicillins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/31/38391?source=related_link\">",
"      An overview of angioedema: Pathogenesis and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/12/44232?source=related_link\">",
"      Chemotherapy-induced alopecia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=related_link\">",
"      Cutaneous complications of conventional chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/63/35834?source=related_link\">",
"      Cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/32/28168?source=related_link\">",
"      Drug-induced lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22986?source=related_link\">",
"      Etiology and pathogenesis of myocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/50/9000?source=related_link\">",
"      Fixed drug eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=related_link\">",
"      Heparin-induced thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30614?source=related_link\">",
"      Hypersensitivity vasculitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/57/43930?source=related_link\">",
"      Infusion reactions to systemic chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30393?source=related_link\">",
"      Neutrophilic dermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/24/21898?source=related_link\">",
"      New onset urticaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37672?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of pemphigus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/56/41863?source=related_link\">",
"      Phenytoin poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=related_link\">",
"      Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/52/841?source=related_link\">",
"      Protein C deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33801?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/2/23594?source=related_link\">",
"      Sulfonamide allergy in non HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/59/1978?source=related_link\">",
"      Vancomycin hypersensitivity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_17_41242="Bacillary angiomatosis";
var content_f40_17_41242=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78497%7EID%2F82760%7EID%2F82759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78497%7EID%2F82760%7EID%2F82759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous lesion of bacillary angiomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous lesion of bacillary angiomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous lesion of bacillary angiomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41242=[""].join("\n");
var outline_f40_17_41242=null;
var title_f40_17_41243="Surface markers resting mature T cells";
var content_f40_17_41243=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Surface markers of resting mature T cells",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD2",
"       </td>",
"       <td>",
"        Binds CD58 (LFA-3), adhesion, SRBC receptor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4",
"       </td>",
"       <td>",
"        Binds MHC class II, associated with lck tyrosine kinase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD5",
"       </td>",
"       <td>",
"        Binds CD72, inhibits activation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD8",
"       </td>",
"       <td>",
"        Binds MHC class I, associated with lck tyrosine kinase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD11a/CD18 (LFA-1)",
"       </td>",
"       <td>",
"        Binds CD54 (ICAM-1), adhesion, activation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD28",
"       </td>",
"       <td>",
"        Binds B7 molecules, regulates T cell activation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD45RA",
"       </td>",
"       <td>",
"        Tyrosine phosphatase, naive T cell marker",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD45RO",
"       </td>",
"       <td>",
"        Tyrosine phosphatase, memory T cell marker",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD69",
"       </td>",
"       <td>",
"        C-type lectin, unknown ligand, early activation marker, unknown function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD152 (CTLA-4)",
"       </td>",
"       <td>",
"        Activation marker, down-regulates T cell responses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD154 (CD40L)",
"       </td>",
"       <td>",
"        Activation marker for CD4 T cells",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ICAM: intercellular adhesion molecule; IL: interleukin; LFA: leukocyte function antigen; MHC: major histocompatibility complex; SRBC: sheep red blood cell.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bonilla Francisco, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41243=[""].join("\n");
var outline_f40_17_41243=null;
var title_f40_17_41244="Manage diastolic HF";
var content_f40_17_41244=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Management of patients with diastolic heart failure",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <p>",
"         &nbsp;",
"         <strong>",
"          Control edema",
"         </strong>",
"        </p>",
"        <ul>",
"         <li>",
"          Low salt diet (eg, &lt;2 g sodium per day)",
"         </li>",
"         <li>",
"          Diuretic (eg, furosemide or hydrochlorothiazide)",
"         </li>",
"         <li>",
"          ACE inhibitor* (eg, enalapril or lisinopril)",
"         </li>",
"         <li>",
"          Angiotensin II receptor blocker* (eg, candesartan, valsartan, or losartan)",
"         </li>",
"         <li>",
"          Aldosterone antagonist* (eg, spironolactone)",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          &nbsp;Rate control",
"         </strong>",
"        </p>",
"        <ul>",
"         <li>",
"          Calcium channel blocker (eg, diltiazem or verapamil)",
"         </li>",
"         <li>",
"          Beta blocker (eg, atenolol, metoprolol)",
"         </li>",
"         <li>",
"          Radiofrequency modification of atrioventricular node and pacing",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         &nbsp;",
"         <strong>",
"          Maintain and restore atrial contraction",
"         </strong>",
"        </p>",
"        <ul>",
"         <li>",
"          Cardioversion",
"         </li>",
"         <li>",
"          Radiofrequency ablation",
"         </li>",
"         <li>",
"          Antiarrhythmic therapy",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         &nbsp;",
"         <strong>",
"          Manage myocardial ischemia",
"         </strong>",
"        </p>",
"        <ul>",
"         <li>",
"          Medical management",
"          <ul>",
"           <li>",
"            Nitrates (eg, isosorbide dinitrate or isosorbide mononitrate)",
"           </li>",
"           <li>",
"            Beta blocker (eg, atenolol or metoprolol)",
"           </li>",
"           <li>",
"            Calcium channel blocker (eg, diltiazem or verapamil)",
"           </li>",
"          </ul>",
"         </li>",
"         <li>",
"          Percutaneons coronary intervention",
"         </li>",
"         <li>",
"          Coronary artery bypass surgery",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Control arterial hypertension&bull;",
"         </strong>",
"        </p>",
"        <ul>",
"         <li>",
"          Diuretic (eg, chlorthalidone or hydrochlorothizide)",
"         </li>",
"         <li>",
"          Beta blocker (eg, atenolol or metoprolol)",
"         </li>",
"         <li>",
"          Calcium channel blocker (eg, amlodipine or felodipine)",
"         </li>",
"         <li>",
"          Angiotensin converting enzyme inhibitor (eg, enalapril or lisinopril)",
"         </li>",
"         <li>",
"          Angiotensin II receptor blocker (eg, candesartan, valsartan, or losartan)",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *The renin-angiotensin-aldosterone system is inhibited&nbsp;by angiotensin converting enzyme inhibitor, angiotensin II receptor blocker, and&nbsp;aldosterone antagonist and thus these agents have a theoretical benefit in promoting regression of left ventricular hypertrophy and preventing myocardial fibrosis. However more data are required to demonstrate whether they improve outcomes in patients with diastolic heart failure. Two of these three&nbsp;agents may be combined in some patients with proper monitoring but use of all three is generally not recommended.",
"     <br>",
"      &bull; The list of medications is not comprehensive but rather includes examples that are in common clinical use or have been included in studies of patients with diastolic dysfunction or heart failure. A more exhaustive list of antihypertensive agents can be found in the guidelines of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. William H. Gaasch.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41244=[""].join("\n");
var outline_f40_17_41244=null;
var title_f40_17_41245="Survival LGG age";
var content_f40_17_41245=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Survival with low-grade glioma as a function of age at diagnosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 323px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Claus, EB, Black, PM. CANCER 2006; 106:1358.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41245=[""].join("\n");
var outline_f40_17_41245=null;
var title_f40_17_41246="Effects combined statin resin";
var content_f40_17_41246=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63912&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63912&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The combination of a statin and a bile acid binding resin is more effective than either alone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 451px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The reduction in low-density lipoprotein (LDL) cholesterol concentration and the increase in high-density lipoprotein (HDL) concentration is greater with the combination of a statin and a bile acid binding resin, given as cholestyramine, when compared with therapy with either drug alone. The effects of both drugs decline exponentially with increasing doses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from The Prevastatin Multicenter Study Group II, Arch Intern Med 1993; 153:1321.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41246=[""].join("\n");
var outline_f40_17_41246=null;
var title_f40_17_41247="CRIE cat allgn extr";
var content_f40_17_41247=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F72410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F72410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    Crossed (radio)-immunoelectrophoresis of cat allergen extract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A) Crossed immunoelectrophoresis (CIE) showing blue stained bell-shaped antigen-antibody precipitates. Each precipitate represents one antigen.",
"    <br>",
"     Panels B and C) Crossed radio-immunoelectrophoresis (CRIE) showing x-ray chromatograms of radio-staining of IgE from individual patients. Each stained precipitate represent reactivity with an allergen that can be identified by comparison with Panel A.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_17_41247=[""].join("\n");
var outline_f40_17_41247=null;
